News

This year’s Barcelona meeting brought together award-winning research data and leaders in the retina field

This article by Liem Trinh, MD highlights his experiences with the AT ELANA® 841P hydrophobic trifocal IOL and the ARTEVO® 750 and ARTEVO® 850 microscopes from ZEISS. Dr. Trinh discusses the benefits of the trifocal design of the AT ELANA 841P IOL and its ability to provide spectacle independence at all distances after cataract surgery. He also shares his positive experiences with the ARTEVO 850 microscope, which offers improved surgical visualization with RGB LED illumination and 3D viewing on a high dynamic range monitor. Additionally, Dr. Trinh discusses the potential benefits of integrated intraoperative optical coherence tomography (OCT) and the redesigned CALLISTO eye user interface.

Two glaucoma specialists discuss pairing patients with the right procedures

Caffeine has been shown to temporarily increase intraocular pressure and reduce blood flow in critical ocular regions

Investigators from Bergen, Norway, and Cleveland, Ohio, collaborated on the predictive model

Research indicates suppressive valacyclovir could help patients avoid keratitis and iritis flare-ups

Patients underwent electropuncture, low-intensity laser stimulation of the ciliary muscle, combined therapy and optical-reflex treatment of accommodation

Moving on from medication “stacks” and the old-school reactive approach

The authors reported significant variability in DED-related symptoms, with higher prevalence rates among university students and administrative workers

Victoria L. Tseng, MD, PhD, discusses SLT, microshunts and what glaucoma specialists can learn from large data sets

During a conversation at the American Academy of Ophthalmology annual meeting in Chicago, T.Y. Alvin Liu, MD, discussed plans for the James P. Gills Jr, MD, & Heather Gills Artificial Intelligence Innovation Center at the Wilmer Eye Institute at Johns Hopkins Medicine.

Michael Singer, MD, shared insights from on his experience using a preservative-free, chloroprocaine ophthalmic gel as anesthesia for intravitreal injections and the results of research on the effectiveness of gel versus traditional drops.

Brent Kramer, MD, presents on an alternative to IV sedation for cataract surgeries and complex cases

Nathan Radcliffe, MD, shared insights from his presentation at the annual meeting of the American Academy of Ophthalmology entitled, "Early cataract extraction for angle closure glaucoma."

Fatemeh Rajaii, MD, PhD, an associate professor at Wilmer Eye Institute, Johns Hopkins, discussed emerging therapies in thyroid eye disease (TED) from her presentation at the American Academy of Ophthalmology’s annual meeting in Chicago.

The company also announced it will seek a strategic partner to continue development of APX3330, an oral small-molecule inhibitor of Ref-1 for the treatment of non-proliferative diabetic retinopathy.

George O. Waring, IV, MD provides insights from an on-demand poster as part of the annual American Academy of Ophthalmology taking place in Chicago, Illinois. This poster shared data on the the 9-month FDA data of the recently approved excimer laser, the TENEO laser, by Bausch + Lomb.

Dr. Arepalli discussed a course focused on ocular conditions related to pregnancy and postpartum care, presented at the American Academy of Ophthalmology (AAO) meeting.

At this year's American Academy of Ophthalmology (AAO) meeting, Jonathan Brugger, MD, spoke about the changing approach to epimacular membranes and the use of brilliant blue in the procedure.

Alexander Fein, MD, spoke with the Eye Care Network to share how to approach a patient presenting with transient vision loss, what this type of vision loss can mean, and what additional testing might be needed to determine the best plan for care.

Jennifer Loh, MD, shared insights from on her presentation at the American Academy of Ophthalmology meeting in Chicago on the effects of CSF-1, which is the lowest effective concentration of pilocarpine approved in the United States.

Meghan Berkenstock, MD, an associate professor of ophthalmology at the Wilmer Eye Institute, provides insights on paper from the uveitis free paper section of AAO 2024, about the use of TriNetX database to assess for the incidence and prevalence of both uveitis and its complications.

Matt Giegengack, MD, explains how injectable corneal endothelial cell therapy can enhance visual acuity and alleviate glare, offering a versatile alternative to current treatments like DMEK.

George O. Waring, IV, MD, provides insights from an on-demand poster as part of the annual American Academy of Ophthalmology taking place in Chicago, Illinois. This poster was titled, "Two-Year Clinical Feasibility Trial Outcomes for a Dual-Optic IOL System for the Treatment of Presbyopia and Cataract."

In visual field progression results, SLT was superior to ocular drops as first-line treatment for patients with glaucoma

Farhad Hafezi, FARVO, MD, PhD, and colleagues reported on results achieved with phototherapeutic keratectomy-assisted, customised, epi-on corneal crosslinking

At this year's American Academy of Ophthalmology (AAO) meeting, John Berdahl, MD, spoke about the recent clinical trials of travoprost and its use in patients with prior SLT.

A novel oral therapeutic showed promising results in a Phase 2 study involving 13 subjects